Interestingly, liver protein abundance of retinol-binding protein 4 (RBP4), described to be associated with insulin resistance and adipose tissue inflammation (Norseen et al., 2012), was lowered with apoA-IV administration (−1.9-fold), thus pointing to apoA-IV being a novel regulator of RBP4. This evidence concerns the gene RBP4 and Insulin resistance.